Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
W. Qian
Observed names:
Qian, WD,
Wendy Qian
Institutions:
Cambridge University Hospitals NHS Foundation Trust,
Cambridge Clinical Trials Unit
Observed institutions:
Cambridge University Hospitals NHS Foundation Trust,
Cambridge Clinical Trials Unit,
University College London
ORCID:
0009-0007-0293-7314
Observed ORCID:
0009-0007-0293-7314
OpenAlex ID:
A5024744790
Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG
2017
·
Kathreena M Kurian
, Michael D Jenkinson
, et al.
·
Neuro-Oncology Practice
·
17
Stanford V (SV) Regimen Versus ABVD for the Treatment of Advanced Hodgkin Lymphoma (HL): Results of a UK NCRI/LTO Randomised Phase II Trial.
2004
·
Peter Johnson
, Peter Hoskin
, et al.
·
Blood
·
2
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease in response to first line salvage chemotherapy regimens.
2003
·
Ardeshna, KM
, Kakouros, N
, et al.
·
UCL Discovery (University College London)
Show more works
View as search
Works count:
4
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type